KINOMEscan™ Binding Assays by DiscoveRx Corporation
The KINOMEscan screening platform employs a novel and proprietary active site-directed competition binding assay to quantitatively measure interactions between test compounds and more than 450 kinase assays and disease relevant mutant variants. This robust and reliable assay technology affords investigators the ability to extensively annotate compounds with accurate, precise and reproducible data. KINOMEscan assays do not require ATP and thereby report true thermodynamic interaction affinities, ...
Read more The supplier does not provide quotations for this product through SelectScience. Browse these related products instead